CA1187798A - Protection des cellules - Google Patents
Protection des cellulesInfo
- Publication number
- CA1187798A CA1187798A CA000399231A CA399231A CA1187798A CA 1187798 A CA1187798 A CA 1187798A CA 000399231 A CA000399231 A CA 000399231A CA 399231 A CA399231 A CA 399231A CA 1187798 A CA1187798 A CA 1187798A
- Authority
- CA
- Canada
- Prior art keywords
- chondroitin sulphate
- chondroitin
- damage
- sulphate
- endothelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000399231A CA1187798A (fr) | 1982-03-24 | 1982-03-24 | Protection des cellules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000399231A CA1187798A (fr) | 1982-03-24 | 1982-03-24 | Protection des cellules |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1187798A true CA1187798A (fr) | 1985-05-28 |
Family
ID=4122386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000399231A Expired CA1187798A (fr) | 1982-03-24 | 1982-03-24 | Protection des cellules |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1187798A (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
-
1982
- 1982-03-24 CA CA000399231A patent/CA1187798A/fr not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
US8084441B2 (en) | 2003-02-19 | 2011-12-27 | Stellar Pharmaceuticals, Inc. | Cystitis treatment with high dose chondroitin sulfate |
US8334276B2 (en) | 2003-02-19 | 2012-12-18 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
US8778908B2 (en) | 2003-02-19 | 2014-07-15 | Stellar International Inc. | Cystitis treatment with high dose chondroitin sulfate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4486416A (en) | Protection of human and animal cells subject to exposure to trauma | |
US4971955A (en) | Protection of human and animal cells during surgical trauma | |
EP0167363B1 (fr) | Glycosaminoglycanes réticulés et leur utilisation | |
KR100307685B1 (ko) | 눈의전방챔버에서축동제및산동제의조절방출법 | |
US5792103A (en) | Viscosurgical method and apparatus | |
Graue et al. | The protective effect of Na-hyaluronate to corneal endothelium | |
JPH0121133B2 (fr) | ||
US5141928A (en) | Ophthalmic medication | |
US5103840A (en) | Viscoelastic collagen gel for ophthalmic surgery | |
US5492936A (en) | Bimodal molecular weight hyaluronate formulations and methods for using same | |
SK127099A3 (en) | Controlled release of pharmaceuticals in the anterior chamber of the eye | |
US20100036387A1 (en) | Viscoelastic Composition for Surgical Procedures | |
US5166048A (en) | Protection of human corneal endothelial cells | |
JP3751017B2 (ja) | 二頂分子量ヒアルロネート製剤およびその使用方法 | |
Harrison et al. | Chondroitin sulfate: a new and effective protective agent for intraocular lens insertion | |
US20200262985A1 (en) | Transparent hydrogel membrane including hyaluronic acid, and contact lens including same | |
WO2006044155A2 (fr) | Compositions ophtalmiques comprenant un lubrifiant, un agent deturgescent, ainsi qu'un glycosaminoglycane et methodes d'utilisation de ces dernieres | |
Soll et al. | Evaluation and protection of corneal endothelium | |
WO1989000044A1 (fr) | Larme artificielle | |
CA2470466C (fr) | Combinaisons de produits viscoelastiques a l'usage de la chirurgie | |
CA1187798A (fr) | Protection des cellules | |
Hoopes | Sodium hyaluronate (Healon®) in anterior segment surgery: A review and a new use in extracapsular surgery | |
Arshinoff et al. | HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation | |
JPH0660200B2 (ja) | 眼に使用するための粘弾性コラ−ゲン溶液 | |
JPH0122248B2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |